Document ID: chunk:federal_register_of_legislation:F2021L01628:reg:9
Version: federal_register_of_legislation:F2021L01628
Segment Type: reg
Provision Reference: reg 9
Character Range: 3804–5725

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting motor neurone disease or death from motor neurone disease with the circumstances of a person's relevant service:
(1)          having smoked tobacco products in an amount of at least 10 pack-years before the clinical onset of motor neurone disease;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(2)          being exposed to lead as specified before the clinical onset of motor neurone disease, where the first exposure occurred at least 5 years before the clinical onset of motor neurone disease;
Note: being exposed to lead as specified is defined in the Schedule 1 - Dictionary.
(3)          inhaling formaldehyde for a cumulative total of at least 5,000 hours:
(a)          at a level of at least 1 part per million; or
(b)          resulting in sensory irritation of the eyes or nose;
at least 3 years before the clinical onset of motor neurone disease;
(4)          having smoked tobacco products in an amount of at least 10 pack-years before the clinical worsening of motor neurone disease;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(5)          being exposed to lead as specified before the clinical onset of motor neurone disease, where the first exposure occurred at least 5 years before the clinical worsening of motor neurone disease;
Note: being exposed to lead as specified is defined in the Schedule 1 - Dictionary.
(6)          inhaling formaldehyde for a cumulative total of at least 5,000 hours:
(a)          at a level of at least 1 part per million; or
(b)          resulting in sensory irritation of the eyes or nose;
at least 3 years before the clinical worsening of motor neurone disease;
(7)          inability to obtain appropriate clinical management for motor neurone disease.